| Aug 13 |
iCAD Non-GAAP EPS of -$0.07 in-line, revenue of $5M beats by $0.57M
|
| Aug 13 |
iCAD Reports Financial Results for Second Quarter Ended June 30, 2024
|
| Aug 6 |
iCAD to Report Second Quarter 2024 Financial Results on August 13, 2024
|
| Jul 29 |
iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography
|
| Jun 26 |
iCAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024
|
| Jun 4 |
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
|
